Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL30240028 | 0.94 | — | — | |
| SCHEMBL29390 | 0.88 | ALDH1A1 (0.32) | — | |
| Bromide SCHEMBL12500813 | 0.86 | ALDH1A1 (0.31) | — | |
| Hydrochloric Acid SCHEMBL29697222 | 0.86 | ALDH1A1 (0.31) | — | |
| SCHEMBL9067234 | 0.82 | KMT2A (0.39) | — | |
| SCHEMBL15657208 | 0.82 | KMT2A (0.39) | — | |
| Water SCHEMBL2041500 | 0.81 | — | — | |
| SCHEMBL31623967 | 0.81 | — | — | |
| Hydrochloric Acid SCHEMBL8415719 | 0.80 | SMN1; SMN2 (0.38) | — | |
| Bromide SCHEMBL3418571 | 0.80 | HTT (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3459975-B1 | POLYMERIC ACID CATALYSTS AND USES THEREOF | DSM NUTRITIONAL PRODUCTS LLC (US) | 2024-10-02 | — | — | EP | claimed |
| EP-3166981-B1 | OLIGOSACCHARIDE COMPOSITIONS AND METHODS FOR PRODUCING THEREOF | DSM NUTRITIONAL PRODUCTS LLC (US) | 2026-05-13 | — | — | EP | disclosed |
| US-12514267-B2 | Oligosaccharide compositions for use as animal feed and methods of producing thereof | DSM NUTRITIONAL PRODUCTS, LLC (US) | 2026-01-06 | — | — | US | disclosed |
| US-12410206-B2 | Oligosaccharide compositions and methods of use thereof for reducing ammonia levels | DSM NUTRITIONAL PRODUCTS, LLC (US) | 2025-09-09 | — | — | US | disclosed |
| US-20250057202-A1 | OLIGOSACCHARIDE COMPOSITIONS FOR USE AS FOOD INGREDIENTS AND METHODS OF PRODUCING THEREOF | DSM NUTRITIONAL PRODUCTS LLC (US) | 2025-02-20 | — | — | US | disclosed |
| EP-3459975-B1 | POLYMERIC ACID CATALYSTS AND USES THEREOF | DSM NUTRITIONAL PRODUCTS LLC (US) | 2024-10-02 | — | — | EP | disclosed |
| US-20230255240-A1 | OLIGOSACCHARIDE COMPOSITIONS FOR USE AS ANIMAL FEED AND METHODS OF PRODUCING THEREOF | MIDORI USA, INC. | 2023-08-17 | — | — | US | disclosed |
| US-11697692-B2 | Methods of producing glycan polymers | DSM NUTRITIONAL PRODUCTS, LLC (US) | 2023-07-11 | — | — | US | disclosed |
| EP-4205553-A1 | OLIGOSACCHARIDE COMPOSITIONS FOR USE ANIMAL FEED AND METHODS OF PRODUCING THEREOF | DSM Nutritional Products, LLC (US) | 2023-07-05 | — | — | EP | disclosed |
| US-11653676-B2 | Oligosaccharide compositions for use as animal feed and methods of producing thereof | DSM NUTRITIONAL PRODUCTS, LLC (US) | 2023-05-23 | — | — | US | disclosed |
| US-11584805-B2 | Oligosaccharide compositions and methods for producing thereof | DSM NUTRITIONAL PRODUCTS, LLC (US) | 2023-02-21 | — | — | US | disclosed |
| US-20220409644-A1 | ANIMAL THERAPEUTIC AND FEED COMPOSITIONS AND METHODS OF USE | DSM NUTRITIONAL PRODUCTS, LLC | 2022-12-29 | — | — | US | disclosed |
| US-20220400728-A1 | OLIGOSACCHARIDE COMPOSITIONS FOR USE AS FOOD INGREDIENTS AND METHODS OF PRODUCING THEREOF | CADENA BIO INC (US) | 2022-12-22 | — | — | US | disclosed |
| EP-3636077-B1 | OLIGOSACCHARIDE COMPOSITIONS FOR USE ANIMAL FEED AND METHODS OF PRODUCING THEREOF | CADENA BIO INC (US) | 2022-11-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230255240-A1 | OLIGOSACCHARIDE COMPOSITIONS FOR USE AS ANIMAL FEED AND METHODS OF PRODUCING THEREOF | FUT5, FUT6, OSTC | TDP1 4759/4885 |
| US-11584805-B2 | Oligosaccharide compositions and methods for producing thereof | OSTC, FUT5, FUT6 | TDP1 4531/4885 |
| US-11653676-B2 | Oligosaccharide compositions for use as animal feed and methods of producing thereof | FUT5, FUT6, OSTC | TDP1 4759/4885 |
| US-20220409644-A1 | ANIMAL THERAPEUTIC AND FEED COMPOSITIONS AND METHODS OF USE | FUT6, FUT5, PIGS | TDP1 4614/4885 |
| US-12410206-B2 | Oligosaccharide compositions and methods of use thereof for reducing ammonia levels | OAT, OTC, FUCA2 | TDP1 2705/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.